Real-time imaging and quantification of amyloid-β peptide aggregates by novel quantum-dot nanoprobes

Kiyotaka Tokuraku, Meg Marquardt, Tsuneya Ikezu

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Protein aggregation plays a major role in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease. However, direct real-time imaging of protein aggregation, including oligomerization and fibrillization, has never been achieved. Here we demonstrate the preparation of fluorescent semiconductor nanocrystal (quantum dot; QD)-labeled amyloid-b peptide (QDAβ) and its advanced applications. Methodology/Principal Findings: The QDAβ construct retained Aβ oligomer-forming ability, and the sizes of these oligomers could be estimated from the relative fluorescence intensities of the imaged spots. Both QDAβ coaggregation with intact Aβ42 and insertion into fibrils were detected by fluorescence microscopy. The coaggregation process was observed by real-time 3D imaging using slit-scanning confocal microscopy, which showed a typical sigmoid curve with 1.5 h in the lag-time and 12 h until saturation. Inhibition of coaggregation using an anti-Aβ antibody can be observed as 3D images on a microscopic scale. Microglia ingested monomeric QDAβ more significantly than oligomeric QDAβ, and the ingested QDAβ was mainly accumulated in the lysosome. Conclusions/Significance: These data demonstrate that QDAβ is a novel nanoprobe for studying Aβ oligomerization and fibrillization in multiple modalities and may be applicable for high-throughput drug screening systems.

Original languageEnglish (US)
Article numbere8492
JournalPloS one
Volume4
Issue number12
DOIs
StatePublished - 2009

Fingerprint

Dive into the research topics of 'Real-time imaging and quantification of amyloid-β peptide aggregates by novel quantum-dot nanoprobes'. Together they form a unique fingerprint.

Cite this